Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RCT Comparing Different Ribavirin Dosages and Durations of Treatment in Combination With Peginterferon in HCV Genotypes 2 and 3 (WRITE)

NCT01380938 is registered in ClinicalTrials.gov with Casa Sollievo della Sofferenza IRCCS as lead sponsor.

NCT NCT01380938
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01380938 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RCT Comparing Different Ribavirin Dosages and Durations of Treatment in Combination With Peginterferon in HCV Genotypes 2 and 3 (WRITE)
Lead sponsor
Casa Sollievo della Sofferenza IRCCS
Phase
Phase 3
Overall status
Completed
Start date
December 1, 2018
Completion date
November 30, 2019
Enrollment
1,150 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis